We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
57 hedge funds and large institutions have $206M invested in Larimar Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
700% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 2
33% more funds holding
Funds holding: 43 → 57 (+14)
0.98% less ownership
Funds ownership: 92.79% → 91.81% (-0.98%)
32% less capital invested
Capital invested by funds: $305M → $206M (-$99M)
33% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 15
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
57
Holders Change
+14
Holders Change %
+32.56%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
16
Increased
10
Reduced
15
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$7.73M |
| 2 |
Millennium Management
New York
|
+$5.76M |
| 3 |
CCM
CAAS Capital Management
New York
|
+$3.98M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.93M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.82M |
Top Sellers
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$18.5M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$8.81M |
| 3 |
O
OrbiMed
New York
|
-$4.89M |
| 4 |
JGC
J. Goldman & Co
New York
|
-$1.11M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$578K |
